// COMPANY
Pathos AI
SECTOR BIOTECHMENTIONS 1LAST SEEN AUGUST 6, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Axios Pro Rata·AUGUST 6, 2026
“Pathos AI, a Chicago-based AI drug developer, is raising up to $300m in Series E funding at an approximately $3b valuation.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.